SACTSONJ
TBPH icon

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Theravance Biopharma TBPH Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,000
Closed -$208K – 220
2020
Q1 		$208K Hold
9,000
– – 0.12% 183
2019
Q4 		$233K Buy
+9,000
New +$175K 0.1% 211

Other funds holding TBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's TBPH Position: Q2 2020 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Theravance Biopharma (TBPH) in Q2 2020, closing a stake of 9,000 shares — an estimated $208K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in TBPH in Q4 2019 and held it in 2 quarters. The position peaked at $233K in Q4 2019. 125 funds tracked by Wall St. Rank hold TBPH as of Q2 2020.

  • Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Theravance Biopharma position as of Q2 2020 after selling out during the quarter.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey sold 9,000 Theravance Biopharma shares in Q2 2020, an estimated $208K.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Theravance Biopharma in Q4 2019 and held it in 2 quarters.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey's Theravance Biopharma position peaked at $233K in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2020.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2020, filed 3 Aug 2020.